# Sitagliptin Umbilical Cord Blood Transplant Study

> **NCT00862719** · PHASE2 · COMPLETED · sponsor: **Indiana University** · enrollment: 29 (actual)

## Conditions studied

- Leukemia, Myeloid, Acute
- Acute Lymphoblastic Leukemia
- Myelodysplasia
- Leukemia, Myelogenous, Chronic
- Lymphoma, Non-Hodgkin

## Interventions

- **DRUG:** Sitagliptin

## Key facts

- **NCT ID:** NCT00862719
- **Lead sponsor:** Indiana University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03
- **Primary completion:** 2012-11
- **Final completion:** 2015-02
- **Target enrollment:** 29 (ACTUAL)
- **Last updated:** 2016-10-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00862719

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00862719, "Sitagliptin Umbilical Cord Blood Transplant Study". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00862719. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*